Marijuana

April 24, 2023 | Alcohol, Controlled Substances, Fentanyl, Marijuana, Methamphetamine, Opioids, Prescription Drugs, Public Health, Reports & Studies, Stimulants, Substance Misuse, Synthetic Drugs

The purpose of this report was to assess immediate and sustained changes in overall illicit substance ingestion rates among children younger than six before and during the COVID-19 pandemic and to examine changes by substance type, including amphetamines, benzodiazepines, cannabis, cocaine, ethanol, and, opioids. Researchers concluded that there was a sustained increase in illicit substance ingestion during the pandemic and that additional studies are needed to contextualize these findings in the setting of pandemic-related stress....

January 6, 2023 | Controlled Substances, Fact Sheets, Fentanyl, Kratom, Marijuana, Methamphetamine, Novel Psychoactive Substances, Opioids, Prescription Drugs, Stimulants, Substance Misuse, Synthetic Drugs

Millions of people throughout the world use social media platforms (or “apps”) providing an easy avenue to reach a large number of people. Legitimate businesses are not the only ones to use social media apps as a marketing tool. In recent years, drug dealers have turned to such apps to solicit buyers and arrange sales. This fact sheet examines the growing use of social media, by drug suppliers, to surreptitiously advertise to a wide audience, by using apps that offer encrypted or disappearing messages....

October 8, 2019 | Marijuana, Reports & Studies

Every year since 2013 the Rocky Mountain High Intensity Drug Trafficking Area (RMHIDTA) has published an annual report that tracks the overall impact of the legalization of recreational marijuana in the state of Colorado.  The stated purpose of these reports is to provide data that informs policy makers as they make decisions about marijuana legalization....

October 8, 2019 | Marijuana, Reports & Studies

The co-authors of this recently released study used opioid mortality data obtained from the U.S. Centers for Disease Control and Prevention to compare opioid death rate trends in each marijuana-legalizing state and the District of Columbia prior to and after medicinal and recreational legalization implementation with associated trends in non-legalizing states. 78% of legalizing jurisdictions showed a statistically significant acceleration of opioid death rates after legalization implementation at greater rates than the pre-legalization rate or the concurrent rate in non-legalizing states....